Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women

• Published in: Journal of Korean medical science Vol. 30; no. 12; pp. 1777 - 1783
• Main Authors: Cho, Hye Yon, Park, Sung Ho, Park, Young Han, Kim, Hong Bae, Kang, Jung Bae, Hong, Seung Hwa, Kyung, Min Sun
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Academy of Medical Sciences 01.12.2015; 대한의학회
• Subjects: Algorithms; Area Under Curve; Biomarkers, Tumor - blood; CA-125 Antigen - blood; Carcinoma, Ovarian Epithelial; Case-Control Studies; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial - blood; Neoplasms, Glandular and Epithelial - diagnosis; Original; Ovarian Neoplasms - blood; Ovarian Neoplasms - diagnosis; Predictive Value of Tests; Prospective Studies; Proteins - metabolism; Reference Values; Republic of Korea; ROC Curve; 의학일반; Republic of Korea; Tumor Markers, Biological; Ovarian Neoplasms; CA125 Antigen; HE4; ROMA
• ISSN: 1011-8934; 1598-6357; 1598-6357
• DOI: 10.3346/jkms.2015.30.12.1777

This study is a multi-center clinical study, which aimed to compare CA125, HE4, and risk of ovarian malignancy algorithm (ROMA) in predicting epithelial ovarian cancer of Korean women with a pelvic mass. Prospectively, serum from 90 Korean women with ovarian mass was obtained prior to surgery. For control group, serum from 79 normal populations without ovarian mass was also obtained. The HE4 and CA125 data were registered and evaluated separately and ROMA was calculated for each sample. Total 67 benign tumors and 23 ovarian cancers were evaluated. Median serum levels of HE4 and CA125, and ROMA score were significantly higher in patients with ovarian cancer than those with benign ovarian tumor and normal population (P < 0.001). In ROC curve analysis for women with a pelvic mass, area under the curve (AUC) for HE4 and ROMA was higher than CA125. Statistical differences in each study compared to CA125 were marginal (P compared to CA125; 0.082 for HE4 and 0.069 for ROMA). Sub-analysis revealed that AUC for HE4 and ROMA was higher than AUC for CA125 in post-menopausal women with a pelvic mass, but there were no statistically significant differences (P compared to CA125; 0.160 for HE4 and 0.127 for ROMA). Our data suggested that both HE4 and ROMA score showed better performance than CA125 for the detection of ovarian cancer in women with a pelvic mass. HE4 and ROMA can be a useful independent diagnostic marker for epithelial ovarian cancer in Korean women.